Glienty 2 mg Tablet (Glymeperide)

Adult dose

Dosage is adjusted individually for each patient. Swallow without chewing with more than 1/2 cup of water. Administer orally once a day. It should be taken before breakfast or just before the first meal. The initial dose for monotherapy is started with Glymeperide 1 mg once daily. If necessary, the dose can be increased by 1 mg at intervals of 1–2 weeks, and generally, there is little additional benefit above a dose of 4 mg. A maximum of 6 mg or 8 mg may be considered.

This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or those in a comatose state. Patients allergic to this medication, its ingredients, or sulfonylurea drugs should also avoid it. Patients with severe liver or kidney dysfunction are recommended to switch to insulin therapy instead of using this medication. Women who are pregnant, may become pregnant, or are breastfeeding should not take this medication. Insulin therapy is necessary for patients with severe infections, post-surgery, or substantial trauma, hence this medication should not be used. Patients who cannot properly absorb food due to diarrhea or vomiting may be at risk of hypoglycemia and should be cautious. This medication contains lactose, so patients with genetic lactose intolerance should not take it. During the initial week of treatment, there is a high risk of hypoglycemia, so blood sugar should be carefully monitored. Special caution is needed in the elderly, uncooperative patients, those with poor nutritional status or who skip meals, and when the balance between exercise and diet is not maintained. Patients who frequently consume alcohol or have compromised liver or kidney function are also at a higher risk of hypoglycemia. Additionally, patients with endocrine diseases such as thyroid, pituitary, or adrenal disorders, or those who overdose on this medication should be cautious. When used in combination with other medications, interactions may affect blood sugar control, so it should always be discussed with a physician. This medication contains Yellow No. 4 (Tartrazine), which may cause allergic reactions in susceptible patients. Due to the blood-sugar-lowering action of this medication, hypoglycemic symptoms may occur. Symptoms of hypoglycemia can include headaches, severe hunger, nausea, fatigue, anxiety, decreased concentration, confusion, blurred vision, dizziness, drowsiness, and loss of consciousness. In severe cases, it may lead to seizures or coma, so if hypoglycemic symptoms appear, immediate intake of sugar or consultation with medical personnel is necessary. Rarely, initial administration may cause blurred vision, digestive disorders, liver function abnormalities, blood disorders, or allergic reactions, so any unusual symptoms should be reported to a healthcare provider. When taking this medication, it is important to adhere to dietary and exercise regimens, and to take the medication regularly. Quickly consuming sugar during hypoglycemia can alleviate symptoms, so always carrying sugar is advisable. Patients and families should be thoroughly informed about hypoglycemic symptoms, treatments, and risk factors. If blood sugar control is insufficient or lifestyle changes occur, consultation with a physician for dose adjustment may be necessary. While taking other medications, interactions with this medication may occur, so patients must inform healthcare personnel of any concurrently used drugs. Care should be taken when using medications that affect enzymes that break down drugs in the liver or medications that raise or lower blood sugar levels. Alcohol consumption should be avoided as it can affect blood sugar control with this medication. Pregnant or breastfeeding women should not take this medication and, if necessary, switching to insulin therapy is safer. For children under 18 years of age, the safety and efficacy of this medication have not been established, so its use is not recommended. In elderly patients, who may have reduced kidney function, careful dosage adjustment is advised. In cases of overdose, severe hypoglycemia may occur, so immediate visit to a healthcare institution for appropriate treatment is necessary. In emergencies, glucose injections should be used to rapidly restore blood sugar, and subsequent monitoring for potential hypoglycemia recurrence should continue for at least 24 to 48 hours. This medication should be kept out of the reach of children and stored in the original container sealed properly.

Serious side effects

Hives, severe swelling (edema), difficulty breathing, hypertension, shock, anaphylaxis, angioedema, skin and mucosal reaction syndrome (Stevens-Johnson syndrome), liver function abnormalities (hepatitis, jaundice), severe hypoglycemia (seizures, loss of consciousness, coma), thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, agranulocytosis, pancytopenia, thrombocytopenic purpura.

Mild side effects

• Headache
• severe hunger
• nausea
• vomiting
• fatigue
• sleep disturbances
• anxiety
• aggression
• decreased concentration
• reduced agility or activity level

This medication should be stored in a tightly sealed container to protect it from air and moisture. Additionally, it is advisable to store it at a temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication.

Appearance

Green rectangular tablet

Package unit

30 tablets/bottle, 200 tablets/bottle